20 articles
A mechanistic deep-dive into cutting-edge anti-inflammaging interventions — from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.
New targeted therapies and biomarker-driven approaches are revolutionizing RA management, potentially improving healthspan for millions.
Delphi study of 166 Italian neurologists establishes guidelines for individualized MS therapy based on patient needs and drug characteristics.
Revolutionary precision immunotherapies use AI and cellular engineering to target lupus at its source, offering hope for durable remission.
Advanced genetic analysis reveals new pathways to personalized RA therapy, addressing treatment failures in 30-40% of patients.
Master the molecular architecture of complement dysregulation in aging — from regulatory protein biochemistry to cutting-edge therapeutic targets — and understand how precision interventions can restore balance without dismantling immunity.
Go beyond inflammaging basics to understand how aging reshapes immune cell populations, triggers the SASP, and locks the body into a state of chronic low-grade inflammation at the molecular level.
Breakthrough therapy targeting B cells demonstrates significant improvement in lupus symptoms with sustained benefits over one year.
Researchers analyzed 38 immune system structures to develop AI-powered, personalized treatments for autoimmune diseases.
New research reveals mortality from this rare immune disorder varies by time, potentially improving treatment strategies.
BNT162b2 mRNA vaccine induces special immune cells that protect against severe illness and may slow aging-related decline.
Stanford researchers used modified immune proteins to enhance neurogenesis and cognitive function in aged mouse brains.
Researchers discovered three molecular subtypes explaining why some lupus patients don't respond to standard treatments, opening doors to personalized therapy.
Researchers used blood biomarkers and machine learning to predict which expensive RA treatments work best for individual patients.
A multi-biomarker study finds pwMS show accelerated thymic involution, senescent T cell expansion, and neuroinflammation linked to aging.
New review shows precision biomarkers and biologic drugs are transforming how clinicians select and treat children with persistent cow's milk allergy.
New research identifies immune patterns that could help doctors personalize treatment for young lupus patients.
Psoriatic arthritis patients successfully redesigned a clinical trial to prioritize outcomes that matter most to their daily lives.
New AI tool provides personalized, accessible information for lupus patients, improving disease understanding and care.
Comprehensive review explores how combining genomics, proteomics, and metabolomics advances psoriasis understanding and treatment.
